This practice parameter describes the assessment and treatment of children and adolescents with attention-deficit/ hyperactivity disorder (ADHD) based on the current scientific evidence and clinical consensus of experts in the field. This parameter discusses the clinical evaluation for ADHD, comorbid conditions associated with ADHD, research on the etiology of the disorder, and psychopharmacolo...

This practice parameter describes the assessment and treatment of children and adolescents with attention-deficit/ hyperactivity disorder (ADHD) based on the current scientific evidence and clinical consensus of experts in the field. This parameter discusses the clinical evaluation for ADHD, comorbid conditions associated with ADHD, research on the etiology of the disorder, and psychopharmacolo...

Attention-deficit/hyperactivity disorder (ADHD) is commonly known to occur during childhood, characterized by excessive inattention and/or hyperactivity and impulsivity as well as lack of emotional self-control and motivation. The prevalence of adult ADHD in the general population is estimated to be between 2-5%. The aim of this review is to provide an overview regarding current controversies r...

ABSTRACT Introduction: Attention Deficit Hyperactivity Disorder (ADHD) is a neurobiological disorder of genetic causes that appears in childhood. The main manifestations are inattention, hyperactivity, and emotional impulsivity. It often accompanied by cognitive impairments learning disabilities seriously affect children's life, academic social functions. Objective: Explore the impacts soccer p...

Attention deficit hyperactivity disorder (ADHD) is characterised by inattention, impulsivity, and hyperactivity. The DSM-IV diagnosis of ADHD requires the presence of six of nine items or features that must have been present for at least six months, to have had an onset before 7 years of age, and to have resulted in significant distress or impairment.1 In the general population, the prevalence ...

This practice parameter describes the assessment and treatment of children and adolescents with attention-deficit/ hyperactivity disorder (ADHD) based on the current scientific evidence and clinical consensus of experts in the field. This parameter discusses the clinical evaluation for ADHD, comorbid conditions associated with ADHD, research on the etiology of the disorder, and psychopharmacolo...

Attention-Deficit/Hyperactivity Disorder (ADHD) is one of the most common psychiatric disorders in children and adolescents with a worldwide prevalence of 5%. It is characterized by symptoms of attention deficit and/or hyperactivity/impulsiveness that is maintained for at least six months. ADHD is a neural disorder with structural and functional abnormalities in some areas of the brain. Pharmac...

Recent population-based longitudinal studies concluded that most adults with attention deficit/hyperactivity disorder (ADHD) symptoms would not have a childhood history of ADHD, leading to the concept of adult-onset ADHD. In a large, well-characterized clinical population of 446 adults with a primary complaint of ADHD, we reported a low frequency of adult-onset ADHD (6.9%), being a primary isol...

253 A central premise in the “catecholamine hypothesis” of attention-deficit/hyperactivity disorder (ADHD) is that dopamine (DA) dysfunction leads to clinical symptoms. The hypothesis arises, in part, from the clinical efficacy of methylphenidate, as well as evidence from brain imaging studies that suggest reduced activity in frontal-striatal regions. The theory, however, overlooks the phenotyp...